PHRM 8660 PHARMACEUTICAL MARKETING RIAN MARIE EXTAVOUR; APRIL 11 TH 2013 TRACKING PROJECT: IMS HEALTH

OUTLINE What is IMS Health? What do they do? Sectors served Solutions Timeline and News Report Highlights Conclusion

WHAT IS IMS HEALTH? 1 Provider of information, services and technology for healthcare Combine industry expertise to provide perspectives and in-depth analytics on healthcare dynamics Analytics, commercial services and consulting Operations in over 100 countries; process over 4 billion transactions per year Clients: Decision-makers in life sciences, payers, providers, policy-makers

FINANCIAL 2 Privately owned – investors (note-holders) Issued full-year 2012 financial results March 4 Conference call on March 8 th Note-holders only

WHAT DO THEY DO AND FOR WHO? 1 Tracking of over 80% global pharmaceutical sales activity Over 1.4 million pharmaceutical products 260+ million de-identified patients worldwide 99,000+ suppliers, 768,000 reporting facilities worldwide 5,000 databases supporting 16,000 healthcare clients Healthcare reference assets including 5 million professionals, with 500,000 organizational linkages and 2.4 million affiliations

SECTORS SERVED Pharmaceutical Companies – Large and Mid-Sized – Small and Biotech – Generics – Specialty Payers Government Providers Pharmacies Consumer Health Pharmaceutical Distributors Financial Community

SOLUTIONS Analytics and Services To optimize commercial effectiveness, clinical decisions and delivery of care Healthcare Measurement Patient, provider and payer insights and market-defining methodologies Consulting Specialized expertise for enabling and accelerating informed decisions

IMS INSTITUTE: HEALTH SERVICES RESEARCH NETWORK 3 Academic researchers Including pharmacy, medicine, law, economics, business, public policy Some member institutions: U of Chicago, Columbia U, Harvard U, Mayo Clinic, MIT, St. Jude’s, Stanford Med Sch, U of Illinois Empirical, policy-relevant studies To improve quality and cost-effectiveness of healthcare More than 60 active projects including current aspects of healthcare reform

RESEARCH PRIORITIES 3 Drug Utilization Trends and Expenditure Xponent™ - local and regional Rx dispensing data National Sales Perspectives™ National Prescription Audit™ - over 70% all Rx activity National trends; therapies adopted, use and expenditure factors Comparative Effectiveness Research Geographic variations in care Xponent™; NPA Real-world applications

HEALTHCARE ANALYTICS AND SERVICES 4 Specialty healthcare analytics Pharma R&D Services Government Solutions Business Process Outsourcing Patient-Centric Solutions – IMS Lifelink™ Pharma Commercial Services Payer Solutions Health Economics and Outcomes Research and Real-world Evidence

TIMELINE 5 Founded 1954 by Bill Frolich (ad exec) and David Dubow (visionary) 1957 – first European syndicated study – audit of pharmaceutical sales in West Germany Further studies in Great Britain, France, Italy, Japan; acquisitions in New Zealand, Australia, South Africa 1969 – entered US market; 1970 – Latin America Series of acquisitions of pharmaceutical audit companies; technologies, databases 1972 – becomes a public company 1998 – independent, public NYSE-listed

TIMELINE CONT’D 5, – taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners Valued at $6 billion 2012 Acquisitions and Collaborations PharmARC (Banglore) analytic services, DecisionView (software solutions); collaborates with Health Intelligence, Inc (BlueCross, BlueShield) Mar – Launches branch in India Leading universities, research institutions, development agencies, government Mar – Acquisition of Appature Software company; cloud-based applications April – IMS Institute for Hcare Informatics Study: Impact of shifting patients to Managed Medicaid Plans

MY IMPRESSION Progressive, Innovative Global reach Relevant Responsive to technological and healthcare advances Proactive – expanding/emerging economies If return to public status – INVEST!

THANK YOU….QUESTIONS??

REFERENCES 1.IMS. Overview. Available at Accessed April 2 nd Business Wire. IMS Health to Issue Full-Year 2012 Financial Results on March 4, Conference Call for Note Holders Scheduled for March 8. Available at Accessed Feb IMS. Health Services Research Network. Available at Accessed Feb 7 th IMS. Healthcare Analytics and Services. Available at Accessed April 2 nd IMS. Company History. Available at Accessed April 2 nd IMS. Press Releases. Available at Accessed April 2 nd